-
CV303
Thomas Scientific
(CV303) Gnomegen COVID-19 RT 1-Step qPCR Kit, 500 rxn
Price: $4,435.94List Price: $4,928.83Gnomegen COVID-19 RT 1-Step qPCR Kit is a RT-qPCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper  respiratory specimens (such as nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract -
iAMP-COVID19-100
Thomas Scientific
iAMP COVID-19 detection kit, 100 tests per pack
Price: $2,437.56List Price: $2,708.40Note:  This product is for in vitro diagnostic use, following guidance from the FDA for Emergency Use Authorizations of tests submitted for approval. This test has not been reviewed by the FDA and results from testing should not be used as -
iAMP-COVID19-SCD
Thomas Scientific
iAMP COVID-19 sample collection device, 100 devices per pack
Price: $317.17List Price: $352.41iAMP COVID-19 sample collection device, 100 devices per pack -
R00135
Thomas Scientific
SNPsig SARS-CoV-2 Real-Time PCR Mutation Detection/Allelic Discrimination Kits (20H/501Y.V2) (SA)
Price: $1,240.08List Price: $1,377.87An alternative to next generation sequencing and S gene target failure (SGTF), it enables scientists to analyze and monitor these specific genomic mutations. Pivotal in the role of screening for SARS-CoV-2 Variants for the purpose of genomic -
R00134
Thomas Scientific
SNPsig SARS-CoV-2 Real-Time PCR Mutation Detection/Allelic Discrimination Kits (20J/501Y.V3) (Brazil)
Price: $1,240.08List Price: $1,377.87An alternative to next generation sequencing and S gene target failure (SGTF), it enables scientists to analyze and monitor these specific genomic mutations. Pivotal in the role of screening for SARS-CoV-2 Variants for the purpose of genomic -
R00131
Thomas Scientific
SNPsig SARS-CoV-2 Real-Time PCR Mutation Detection/Allelic Discrimination Kits (N501Y) Variants with the N501 Y mutation (UK, SA and Brazil)
Price: $1,240.08List Price: $1,377.87An alternative to next generation sequencing and S gene target failure (SGTF), it enables scientists to analyze and monitor these specific genomic mutations. Pivotal in the role of screening for SARS-CoV-2 Variants for the purpose of genomic